NeoGenomics, Inc. (NASDAQ:NEO)

PRESS RELEASE

published on 12/28/2023 at 14:10, 1 year 11 months ago

NeoGenomics to Appeal Ruling
NeoGenomics, Inc., a leading oncology testing services company, has announced that its subsidiary, NeoGenomics Laboratories, Inc., will appeal the preliminary injunction issued by the United States District Court for the Middle District of North Carolina. The court's ruling stated that Natera, Inc. has demonstrated a likelihood that products using RaDaR technology infringe one of its patents. However, the order allows patients already using RaDaR to continue their use and permits ongoing research projects, studies,
PRESS RELEASE

published on 12/05/2023 at 14:00, 2 years ago

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
NeoGenomics, Inc. to present new data at San Antonio Breast Cancer Symposium highlighting utility of RaDaR for therapy response. The data includes an updated analysis of the TRACER study and the announcement of receipt of the first samples from the SURVIVE clinical trial

NeoGenomics RaDaR Assay San Antonio Breast Cancer Symposium TRACER Study SURVIVE Clinical Trial
PRESS RELEASE

published on 11/14/2023 at 13:00, 2 years 1 month ago

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
PRESS RELEASE

published on 11/06/2023 at 22:05, 2 years 1 month ago

NeoGenomics Reports Third Quarter 2023 Results
PRESS RELEASE

published on 10/24/2023 at 13:00, 2 years 1 month ago

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
PRESS RELEASE

published on 10/17/2023 at 15:20, 2 years 2 months ago

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

Published on 12/18/2025 at 00:55, 2 hours 9 minutes ago

Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 4 minutes ago

Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 3 hours 49 minutes ago

Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 4 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 4 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy

View all ACCESSWIRE

Published on 12/18/2025 at 01:10, 1 hour 54 minutes ago

Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 2 hours 14 minutes ago

Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 4 hours 59 minutes ago

Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 4 hours 59 minutes ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 5 hours 42 minutes ago

EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share

View all EQS

Published on 12/17/2025 at 20:39, 6 hours 25 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 6 hours 25 minutes ago

Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 7 hours 34 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 19:30, 7 hours 34 minutes ago

Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 4 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE

News